Clinical TrialsSearch results
Number of results: 702
Recruiting
- A study of neural mechanism of non-invasive brain stimulation combined rehabilitation training.
- Neurological diseases
- Mukaino Masahiko
- 2020-12-21
Recruiting
- A Study of TAK-341 in Treatment of Multiple System Atrophy
- Multiple System Atrophy
- Nonomura Hidenori
- 2022-12-20
Recruiting
- A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guerin (BCG).
- Non-Muscle Invasive Bladder Neoplasms
- Fujikawa Ei
- 2024-04-23
Recruiting
- A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Yamazaki Hayato
- 2023-07-20
Recruiting
- A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants with Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Yamazaki Hayato
- 2023-04-10
Recruiting
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease
- Chronic Graft-versus-host-disease
- Ono Shintaro
- 2024-04-27
Recruiting
- A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease
- thyroid eye disease(TED)
- Giulio Barteselli
- 2023-09-29
Recruiting
- A STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB IN PATIENTS WITH NMDAR OR LGI1ENCEPHALITIS
- Autoimmune Encephalitis
- James Overell
- 2022-08-26
Recruiting
- A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)
- pediatric participants (from birth to <18 years) undergoing contrast-enhanced MRI
- Myoishi Masafumi
- 2023-07-28
Recruiting
- AB122 Platform study
- Advanced or metastatic solid tumor
- Nasermoaddeli Ali
- 2021-07-27